The effectiveness of the clinical pathways for children hospitalized for the treatment of acute asthma exacerbation
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 14.05.2025. Verfasst von Riko Kanda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. Hauptthemen laut MEDLINE: Asthma, Critical Pathways. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Guidelines for the treatment of bronchial asthma (BA) include several corticosteroids recommended for the treatment of children with acute asthma exacerbation. Clinical pathways (CPs) may contribute to the standardization of the treatment of acute asthma exacerbation and the reduction of treatment‐related incidents. We investigated the effectiveness of CPs in children with acute asthma exacerbation.
Methods
This retrospective study included children hospitalized for acute asthma exacerbation from August 2015 to June 2021. The patients were divided into two groups: before (pre‐CP, n = 236) and after (post‐CP, n = 198) the introduction of CPs for the treatment of acute asthma exacerbation. We compared the outcomes, including the length of hospital stay, types of corticosteroids used, and use of an antimicrobial agent, between the two groups.
Results
Most patients in the post‐CP group were treated with prednisolone or methylprednisolone, whereas several corticosteroids were administered during the pre‐CP period. The proportion of patients treated with antimicrobial agents was lower in the post‐CP group than in the pre‐CP group ( p < 0.001). The length of hospital stay was shorter in the post‐CP group than in the pre‐CP group ( p < 0.001). The re‐admission rates were similar between the two groups. No treatment‐related incidents occurred during the investigation period.
Conclusion
For the treatment of acute asthma exacerbation in children, the introduction of CP was useful for standardizing therapies, reducing inappropriate antimicrobial therapy, and shortening the length of hospital stay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
- Department of Pediatrics, Kitakyushu General Hospital, Kitakyushu, Japan.
- Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan.
ORCID-Profile: Masaru Kawamura, Takayuki Hoshina
Zitieren
APA
Kanda, R., Kawamura, M., Kojiro, M., Fujino, Y., & Hoshina, T. (2025). The effectiveness of the clinical pathways for children hospitalized for the treatment of acute asthma exacerbation. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70073
Vancouver
Kanda R, Kawamura M, Kojiro M, Fujino Y, Hoshina T. The effectiveness of the clinical pathways for children hospitalized for the treatment of acute asthma exacerbation. Pediatrics International. 2025;67(1). doi:10.1111/ped.70073
BibTeX
@article{Kanda2025,
author = {Kanda, Riko and Kawamura, Masaru and Kojiro, Masumi and Fujino, Yoshihisa and Hoshina, Takayuki},
title = {The effectiveness of the clinical pathways for children hospitalized for the treatment of acute asthma exacerbation},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70073}
}
EUVIMED